Cargando…

Polycystic Ovarian Syndrome: Correlation between clinical hyperandrogenism, anthropometric, metabolic and endocrine parameters

OBJECTIVE: To evaluate the correlation between clinical hyperandrogenism-hirsutism assessed by modified Ferriman-Gallwey (F-G) score, anthropometric, metabolic and endocrine parameters among PCOS infertile women. METHODS: This observational study after approval of FRC & ERC of BUMDC was conducte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Ayesha, Karim, Nasim, Ainuddin, Jahan Ara, Fahim, Muhammad Faisal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717481/ https://www.ncbi.nlm.nih.gov/pubmed/31488983 http://dx.doi.org/10.12669/pjms.35.5.742

Ejemplares similares

Serum Leptin and Ghrelin Levels in Women with Polycystic Ovary Syndrome: Correlation with Anthropometric, Metabolic, and Endocrine Parameters
por: Houjeghani, Shiva, et al.
Publicado: (2012)

Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism
por: Kałużna, Małgorzata, et al.
Publicado: (2021)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
por: Guo, Zaixin, et al.
Publicado: (2023)

Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome
por: Li, Na, et al.
Publicado: (2021)

Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome
por: Donbaloğlu, Zeynep, et al.
Publicado: (2022)

A Study of Hormonal and Anthropometric Parameters in Polycystic Ovarian Syndrome
por: Kambale, Tushar, et al.
Publicado: (2023)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014)

New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
por: Soares-Jr, José Maria, et al.
Publicado: (2019)

Metformin Treatment in Type 2 Diabetes in Pregnancy: An Active Controlled, Parallel-Group, Randomized, Open Label Study in Patients with Type 2 Diabetes in Pregnancy
por: Ainuddin, Jahan Ara, et al.
Publicado: (2015)

The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome
por: Akpinar, Funda, et al.
Publicado: (2016)

The association between anthropometric parameters and cardiovascular risk indicators in women with polycystic ovarian syndrome
por: Mirdamadi, Ahmad, et al.
Publicado: (2020)

Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review
por: Paixão, Larissa, et al.
Publicado: (2017)

The Distribution of Stroma and Antral Follicles Differs between Insulin-Resistance and Hyperandrogenism-Related Polycystic Ovarian Syndrome
por: Alviggi, Carlo, et al.
Publicado: (2017)

Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
por: Ethirajulu, Aarthi, et al.
Publicado: (2021)

Postmenopausal Hyperandrogenism due to Ovarian Hyperthecosis
por: Metzker, Laryssa Santos, et al.
Publicado: (2023)

The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
por: Turan, Mahfuz, et al.
Publicado: (2016)

Correlation of Vitamin D with metabolic parameters in polycystic ovarian syndrome
por: Kumar, Arun, et al.
Publicado: (2017)

Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis
por: Yang, Rui, et al.
Publicado: (2016)

Prenatal Hyperandrogenization Induces Metabolic and Endocrine Alterations Which Depend on the Levels of Testosterone Exposure
por: Amalfi, Sabrina, et al.
Publicado: (2012)

Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS
por: Forrester-Dumont, Kim, et al.
Publicado: (2012)

A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills
por: Fattah, Abdul, et al.
Publicado: (2022)

Are Psychosocial Consequences of Obesity and Hyperandrogenism Present in Adolescent Girls with Polycystic Ovary Syndrome?
por: Zachurzok, Agnieszka, et al.
Publicado: (2018)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

Ovarian Hyperthecosis: Hyperandrogenism in a Post-Menopausal Woman
por: Fayad, Christine, et al.
Publicado: (2021)

Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism
por: Rajamani, Krishnakumar, et al.
Publicado: (2022)

Trends in endocrine onomastics: The case of polycystic ovarian syndrome
por: Kalra, Sanjay, et al.
Publicado: (2013)

Impact of transitional care on endocrine and anthropometric parameters in Prader–Willi syndrome
por: Paepegaey, A C, et al.
Publicado: (2018)

Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome
por: Sørensen, Anja E., et al.
Publicado: (2019)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Postmenopausal Hyperandrogenism
por: Lal, Rayhan A, et al.
Publicado: (2018)

Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation
por: Sabatini, Mary E, et al.
Publicado: (2011)

Ovarian Stromal Hyperplasia: A Rare Cause of Postmenopausal Hyperandrogenism
por: Lozoya Araque, Teresa, et al.
Publicado: (2020)

Hyperandrogenism associated with an ovarian remnant in a spayed female cat
por: Jones, Sarah A, et al.
Publicado: (2019)

Urinary Phthalate Biomarkers during Pregnancy, and Maternal Endocrine Parameters in Association with Anthropometric Parameters of Newborns
por: Hlisníková, Henrieta, et al.
Publicado: (2022)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Effect of “DXB-2030,” a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism
por: Azeemuddin, Mohammed, et al.
Publicado: (2019)

Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022)

Ovarian Steroid Cell Tumor (Not Otherwise Specified): A Case Report of Ovarian Hyperandrogenism
por: Faten, Hadjkacem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6tk8fu61o14sd4of4t9m1j2p28